APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Transluminal Angioplasty Instrument

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Percutaneous Transluminal Angioplasty Instrument Industry Growth and Trends Forecast to 2032

8 January 2026111 pages

Choose your research edition.

Industry ResearchPercutaneous Transluminal Angioplasty Instrument Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Transluminal Angioplasty Instrument Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Percutaneous Transluminal Angioplasty Instrument Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Transluminal Angioplasty Instrument Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Transluminal Angioplasty Instrument Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Percutaneous Transluminal Angioplasty Instrument market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Percutaneous Transluminal Angioplasty Instrument market include Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun and Atrium Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Percutaneous Transluminal Angioplasty Instrument market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Percutaneous Transluminal Angioplasty Instrument market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Percutaneous Transluminal Angioplasty Instrument market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Percutaneous Transluminal Angioplasty Instrument.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Percutaneous Transluminal Angioplasty Instrument market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Percutaneous Transluminal Angioplasty Instrument Market by Company

Abbott

Boston Scientific

Medtronic

Terumo Medical

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

Asahi Intecc

Cardinal

Integer

Cook Medical

TE Connectivity

Merit

SP Medical

Percutaneous Transluminal Angioplasty Instrument Segment by Type

Introducer

Angiographic Catheter

Balloon Catheter

Guide Wire

Stent

Others

Percutaneous Transluminal Angioplasty Instrument Segment by Application

Below 40 Years Old

40 ~ 60 Years Old

Above 60 Years Old

Percutaneous Transluminal Angioplasty Instrument Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Transluminal Angioplasty Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Transluminal Angioplasty Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Transluminal Angioplasty Instrument.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Percutaneous Transluminal Angioplasty Instrument companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Percutaneous Transluminal Angioplasty Instrument Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2021-2026) Table 4. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2027-2032) Table 6. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2026) Table 9. Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share Forecasted by Type (2027-2032) Table 11. North America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2026) Table 24. Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share Forecasted by Application (2027-2032) Table 26. North America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Percutaneous Transluminal Angioplasty Instrument Industry Trends Table 37. Percutaneous Transluminal Angioplasty Instrument Industry Drivers Table 38. Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges Table 39. Percutaneous Transluminal Angioplasty Instrument Industry Restraints Table 40. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Company (2021-2026) Table 42. Global Percutaneous Transluminal Angioplasty Instrument Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Percutaneous Transluminal Angioplasty Instrument Key Company Headquarters & Area Served Table 44. Global Percutaneous Transluminal Angioplasty Instrument Company, Product Type & Application Table 45. Global Percutaneous Transluminal Angioplasty Instrument Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Percutaneous Transluminal Angioplasty Instrument by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 52. Abbott Recent Development Table 53. Boston Scientific Company Information Table 54. Boston Scientific Business Overview Table 55. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 57. Boston Scientific Recent Development Table 58. Medtronic Company Information Table 59. Medtronic Business Overview Table 60. Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 62. Medtronic Recent Development Table 63. Terumo Medical Company Information Table 64. Terumo Medical Business Overview Table 65. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 67. Terumo Medical Recent Development Table 68. Lepu Medical Company Information Table 69. Lepu Medical Business Overview Table 70. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 72. Lepu Medical Recent Development Table 73. MicroPort Company Information Table 74. MicroPort Business Overview Table 75. MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 77. MicroPort Recent Development Table 78. Biosensors Company Information Table 79. Biosensors Business Overview Table 80. Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 82. Biosensors Recent Development Table 83. B.Braun Company Information Table 84. B.Braun Business Overview Table 85. B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 87. B.Braun Recent Development Table 88. Atrium Medical Company Information Table 89. Atrium Medical Business Overview Table 90. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 92. Atrium Medical Recent Development Table 93. Biotronik Company Information Table 94. Biotronik Business Overview Table 95. Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 97. Biotronik Recent Development Table 98. Asahi Intecc Company Information Table 99. Asahi Intecc Business Overview Table 100. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 102. Asahi Intecc Recent Development Table 103. Cardinal Company Information Table 104. Cardinal Business Overview Table 105. Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 107. Cardinal Recent Development Table 108. Integer Company Information Table 109. Integer Business Overview Table 110. Integer Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 112. Integer Recent Development Table 113. Cook Medical Company Information Table 114. Cook Medical Business Overview Table 115. Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 117. Cook Medical Recent Development Table 118. TE Connectivity Company Information Table 119. TE Connectivity Business Overview Table 120. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 122. TE Connectivity Recent Development Table 123. Merit Company Information Table 124. Merit Business Overview Table 125. Merit Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 127. Merit Recent Development Table 128. SP Medical Company Information Table 129. SP Medical Business Overview Table 130. SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 132. SP Medical Recent Development Table 133. North America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2026) Table 136. North America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Country (2027-2032) Table 138. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2026) Table 141. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2026) Table 146. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Country (2027-2032) Table 148. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2026) Table 151. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2026) Table 156. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Percutaneous Transluminal Angioplasty Instrument Product Image Figure 3. Global Percutaneous Transluminal Angioplasty Instrument Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 5. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region: 2025 VS 2032 Figure 6. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2021-2032) Figure 7. North America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Introducer Image Figure 13. Global Introducer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Angiographic Catheter Image Figure 15. Global Angiographic Catheter Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Balloon Catheter Image Figure 17. Global Balloon Catheter Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Guide Wire Image Figure 19. Global Guide Wire Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Stent Image Figure 21. Global Stent Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Percutaneous Transluminal Angioplasty Instrument Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Type 2025 VS 2032 Figure 26. North America Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2032) Figure 27. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2032) Figure 29. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2032) Figure 31. Below 40 Years Old Image Figure 32. Global Below 40 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. 40 ~ 60 Years Old Image Figure 34. Global 40 ~ 60 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Above 60 Years Old Image Figure 36. Global Above 60 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Percutaneous Transluminal Angioplasty Instrument Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Application 2025 VS 2032 Figure 39. North America Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2032) Figure 40. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2032) Figure 42. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Percutaneous Transluminal Angioplasty Instrument Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Percutaneous Transluminal Angioplasty Instrument Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 49. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 52. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 55. Latin America Percutaneous Transluminal Angioplasty Instrument Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Percutaneous Transluminal Angioplasty Instrument Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 58. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Introducer
  • Angiographic Catheter
  • Balloon Catheter
  • Guide Wire
  • Stent
  • Others
Applications
  • Below 40 Years Old
  • 40 ~ 60 Years Old
  • Above 60 Years Old
Companies covered
  • Abbott
  • Boston Scientific
  • Medtronic
  • Terumo Medical
  • Lepu Medical
  • MicroPort
  • Biosensors
  • B.Braun
  • Atrium Medical
  • Biotronik
  • Asahi Intecc
  • Cardinal
  • Integer
  • Cook Medical
  • TE Connectivity
  • Merit
  • SP Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2032)
  5. 1.4.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2026)
  6. 1.4.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2027-2032)
  7. 1.5 Key Regions Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  8. 1.5.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (2021-2032)
2 Percutaneous Transluminal Angioplasty Instrument Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Introducer
  3. 2.1.2 Angiographic Catheter
  4. 2.1.3 Balloon Catheter
  5. 2.1.4 Guide Wire
  6. 2.1.5 Stent
  7. 2.1.6 Others
  8. 2.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  9. 2.2.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Percutaneous Transluminal Angioplasty Instrument Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Regions
  13. 2.3.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Type (2021-2026)
3 Percutaneous Transluminal Angioplasty Instrument Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Below 40 Years Old
  3. 3.1.2 40 ~ 60 Years Old
  4. 3.1.3 Above 60 Years Old
  5. 3.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  6. 3.2.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Percutaneous Transluminal Angioplasty Instrument Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Regions
  10. 3.3.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Percutaneous Transluminal Angioplasty Instrument Industry Trends
  2. 4.2 Percutaneous Transluminal Angioplasty Instrument Industry Drivers
  3. 4.3 Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges
  4. 4.4 Percutaneous Transluminal Angioplasty Instrument Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Percutaneous Transluminal Angioplasty Instrument Revenue (2021-2026)
  2. 5.2 Global Percutaneous Transluminal Angioplasty Instrument Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Percutaneous Transluminal Angioplasty Instrument Key Company Headquarters & Area Served
  4. 5.4 Global Percutaneous Transluminal Angioplasty Instrument Company, Product Type & Application
  5. 5.5 Global Percutaneous Transluminal Angioplasty Instrument Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Percutaneous Transluminal Angioplasty Instrument Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Percutaneous Transluminal Angioplasty Instrument Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Percutaneous Transluminal Angioplasty Instrument Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Boston Scientific
  8. 6.2.1 Boston Scientific Company Information
  9. 6.2.2 Boston Scientific Business Overview
  10. 6.2.3 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  12. 6.2.5 Boston Scientific Recent Developments
  13. 6.3 Medtronic
  14. 6.3.1 Medtronic Company Information
  15. 6.3.2 Medtronic Business Overview
  16. 6.3.3 Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  18. 6.3.5 Medtronic Recent Developments
  19. 6.4 Terumo Medical
  20. 6.4.1 Terumo Medical Company Information
  21. 6.4.2 Terumo Medical Business Overview
  22. 6.4.3 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  24. 6.4.5 Terumo Medical Recent Developments
  25. 6.5 Lepu Medical
  26. 6.5.1 Lepu Medical Company Information
  27. 6.5.2 Lepu Medical Business Overview
  28. 6.5.3 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  30. 6.5.5 Lepu Medical Recent Developments
  31. 6.6 MicroPort
  32. 6.6.1 MicroPort Company Information
  33. 6.6.2 MicroPort Business Overview
  34. 6.6.3 MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  36. 6.6.5 MicroPort Recent Developments
  37. 6.7 Biosensors
  38. 6.7.1 Biosensors Company Information
  39. 6.7.2 Biosensors Business Overview
  40. 6.7.3 Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  42. 6.7.5 Biosensors Recent Developments
  43. 6.8 B.Braun
  44. 6.8.1 B.Braun Company Information
  45. 6.8.2 B.Braun Business Overview
  46. 6.8.3 B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  48. 6.8.5 B.Braun Recent Developments
  49. 6.9 Atrium Medical
  50. 6.9.1 Atrium Medical Company Information
  51. 6.9.2 Atrium Medical Business Overview
  52. 6.9.3 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  54. 6.9.5 Atrium Medical Recent Developments
  55. 6.10 Biotronik
  56. 6.10.1 Biotronik Company Information
  57. 6.10.2 Biotronik Business Overview
  58. 6.10.3 Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  60. 6.10.5 Biotronik Recent Developments
  61. 6.11 Asahi Intecc
  62. 6.11.1 Asahi Intecc Company Information
  63. 6.11.2 Asahi Intecc Business Overview
  64. 6.11.3 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  66. 6.11.5 Asahi Intecc Recent Developments
  67. 6.12 Cardinal
  68. 6.12.1 Cardinal Company Information
  69. 6.12.2 Cardinal Business Overview
  70. 6.12.3 Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  72. 6.12.5 Cardinal Recent Developments
  73. 6.13 Integer
  74. 6.13.1 Integer Company Information
  75. 6.13.2 Integer Business Overview
  76. 6.13.3 Integer Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  78. 6.13.5 Integer Recent Developments
  79. 6.14 Cook Medical
  80. 6.14.1 Cook Medical Company Information
  81. 6.14.2 Cook Medical Business Overview
  82. 6.14.3 Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  84. 6.14.5 Cook Medical Recent Developments
  85. 6.15 TE Connectivity
  86. 6.15.1 TE Connectivity Company Information
  87. 6.15.2 TE Connectivity Business Overview
  88. 6.15.3 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  90. 6.15.5 TE Connectivity Recent Developments
  91. 6.16 Merit
  92. 6.16.1 Merit Company Information
  93. 6.16.2 Merit Business Overview
  94. 6.16.3 Merit Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  96. 6.16.5 Merit Recent Developments
  97. 6.17 SP Medical
  98. 6.17.1 SP Medical Company Information
  99. 6.17.2 SP Medical Business Overview
  100. 6.17.3 SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  102. 6.17.5 SP Medical Recent Developments
7 North America
  1. 7.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  3. 7.3 North America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  3. 8.3 Europe Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  3. 10.3 South America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst